Citigroup’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $199K | Sell |
26,491
-54,509
| -67% | -$410K | ﹤0.01% | 3346 |
|
|
2025
Q1 | $613K | Buy |
81,000
+327
| +0.4% | +$2.48K | ﹤0.01% | 2838 |
|
|
2024
Q4 | $983K | Buy |
80,673
+42,285
| +110% | +$515K | ﹤0.01% | 2611 |
|
|
2024
Q3 | $643K | Buy |
38,388
+16,281
| +74% | +$273K | ﹤0.01% | 2838 |
|
|
2024
Q2 | $386K | Sell |
22,107
-63,467
| -74% | -$1.11M | ﹤0.01% | 2846 |
|
|
2024
Q1 | $1.46M | Buy |
85,574
+75,004
| +710% | +$1.28M | ﹤0.01% | 2083 |
|
|
2023
Q4 | $108K | Sell |
10,570
-12,964
| -55% | -$132K | ﹤0.01% | 3436 |
|
|
2023
Q3 | $213K | Buy |
23,534
+15,308
| +186% | +$139K | ﹤0.01% | 2954 |
|
|
2023
Q2 | $88.5K | Sell |
8,226
-9,013
| -52% | -$97K | ﹤0.01% | 3634 |
|
|
2023
Q1 | $176K | Buy |
17,239
+16,113
| +1,431% | +$165K | ﹤0.01% | 3175 |
|
|
2022
Q4 | $11.9K | Sell |
1,126
-207
| -16% | -$2.18K | ﹤0.01% | 4082 |
|
|
2022
Q3 | $17K | Sell |
1,333
-1,790
| -57% | -$22.8K | ﹤0.01% | 4068 |
|
|
2022
Q2 | $40K | Sell |
3,123
-7,634
| -71% | -$97.8K | ﹤0.01% | 3945 |
|
|
2022
Q1 | $113K | Sell |
10,757
-49,921
| -82% | -$524K | ﹤0.01% | 3667 |
|
|
2021
Q4 | $936K | Buy |
60,678
+57,507
| +1,814% | +$887K | ﹤0.01% | 2620 |
|
|
2021
Q3 | $72K | Buy |
3,171
+2,304
| +266% | +$52.3K | ﹤0.01% | 3805 |
|
|
2021
Q2 | $22K | Sell |
867
-1,603
| -65% | -$40.7K | ﹤0.01% | 4563 |
|
|
2021
Q1 | $103K | Buy |
+2,470
| New | +$103K | ﹤0.01% | 3684 |
|